Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
11.01.24
/
50%
€0.41
Target price
11.01.25
€63.93
Performance (%)
1445.89%
Price
19.09.24
€6.40
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd. has seen massive gains of 1445.89%. This prediction currently runs until 11.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.26
07.08.24
07.08.24
€71.40
07.08.25
07.08.25
2361.54%
19.09.24
19.09.24